Vascular Risk Factors in Patients with Different Subtypes of Ischemic Stroke May Affect Their Outcome after Intravenous tPA.

Intravenous (i.v.) tissue-type plasminogen activator (tPA) is the only approved noninvasive therapy for acute ischemic stroke (AIS). However, after tPA treatment, the outcome of patients with different subtypes of stroke according to their vascular risk factors remains to be elucidated. We aim to ex...

Full description

Bibliographic Details
Main Authors: Yi Dong, Wenjie Cao, Jinma Ren, Deepak S Nair, Sarah Parker, Jan L Jahnel, Teresa G Swanson-Devlin, Judith M Beck, Maureen Mathews, Clayton J McNeil, Manas Upadhyaya, Yuan Gao, Qiang Dong, David Z Wang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4527733?pdf=render